Radiotherapy Market Explore Growth By Top Players Accuray Incorporated, Varian Medical Systems, Inc., Elekta AB, Ion Beam Applications S.A., C.R. Bard, Inc., Isoray Medical, Inc., CIVCO Radiotherapy, Hitachi Ltd., Mevion Medical Systems, Inc., and ProTom

Radiotherapy Market is expected to have a highly positive outlook for the next five years 2018–2026 according to a recently released Radiotherapy Market research report. The report has been added in his large database by Coherent Market Insights.”

The major takeaways in the report are product segment analysis, application segment analysis, regional segment analysis and data of the major Radiotherapy Market players from around the world. The report presents an introductory as well as detailed information about the Radiotherapy Market through a well-organized layout divided into easy to understand chapters.

Download PDF Brochure@ https://www.coherentmarketinsights.com/insight/request-pdf/1320

Radiotherapy uses high-energy radiation beams such as gamma rays, x-rays, and protons to kill cancerous cells by inhibiting growth and multiplication. Radiosurgery is often used before surgery to reduce the size of a tumor prior to removal, or after surgery to destroy the cancerous cells left behind. Various types of radiation therapies such as conformal radiotherapy (CRT), intensity modulated radiotherapy (IMRT), image guided radiotherapy (IGRT), and 4-dimensional radiotherapy are widely used to treat cancer. Internal radiotherapy is given using radioactive material placed inside the body, while external beam radiotherapy delivers x-rays from outside the body, using linear accelerators and other systems. The innovative image-guided radiotherapy is used to integrate better imaging techniques for visualizing cancer tumor.

Market Dynamics

Major factors driving growth of the radiotherapy market include rising prevalence of cancer, increasing adoption of innovative targeted therapies such as radiotherapy due to side effects associated with traditional chemotherapies such as anemia and infection for cancer treatment. According to the World Cancer Research Fund International, 2012, around 14.1 million cancer cases were registered globally, the number of which is projected to rise to 24 million by 2035. This in turn, is expected to increase the demand for radiotherapy over the forecast period. Nevertheless, the opportunities for the key players to provide radiotherapy products in emerging markets with increasing demand for efficacious cancer treatment are anticipated to provide better prospects for market growth in the near future. However, difficulty in tumor visualization experienced during radiotherapy procedures and the dearth of skilled professionals to carry out radiotherapy are factors restraining growth of the radiotherapy market.

Higher efficacy of radiotherapy equipment with enhanced clinical outcomes to drive growth of the global radiotherapy market

Radiotherapy is increasingly being adopted for cancer treatment due to its cost-effectiveness. According to the report by The Mesothelioma Center, radiation therapy accounts for an average US$ 2,000 per treatment, whereas the initial treatment cost of chemotherapy is around US$ 7,000. Also, according to a study published in the Journal named Frontiers of Oncology, 2014, the impact of radiotherapy for cancer cure was 40%, compared to 11% of patients by systemic treatments globally. Also, the Royal College of Radiologists states that radiotherapy is a safe, modern, and an efficient targeted cure, contributing to the cure of 40% of cancers, while drug therapy accounts for 10% of cancer cure among patients. Europe is expected to be the fastest-growing region in the radiotherapy market, owing to the increasing number of government initiatives being undertaken for cancer care, in turn increasing the introduction of novel therapies in the global market. For instance, in 2015, the Swedish Government launched the National Cancer Program to make cancer care more equitable and accessible. Moreover, in 2017, the Swedish Testbed for Innovative Radiotherapy was launched as a collaborative platform to enable healthcare providers and market players in Sweden, to test new technology and methods in clinical settings for the development of innovative radiotherapies for cancer treatment. Also, in 2016, National Health Service, England announced US$ 183 million investment to upgrade radiotherapy investment, ensuring patients get access to the latest leading-edge technology, thereby transforming cancer treatment across England.

Request for Customization@ https://www.coherentmarketinsights.com/insight/request-customization/1320

Major players operating the global radiotherapy market include Accuray Incorporated, Varian Medical Systems, Inc., Elekta AB, Ion Beam Applications S.A., C.R. Bard, Inc., Isoray Medical, Inc., CIVCO Radiotherapy, Hitachi Ltd., Mevion Medical Systems, Inc., and ProTom International, Inc.

Global Radiotherapy Market Taxonomy:

Global Radiotherapy Market, By Product Type:
External Beam Radiation
Compact Advanced Radiotherapy Systems
Cyber Knife
Gamma Knife
Others
Proton Therapy Systems
Synchrotron
Cyclotron
High Energy Linear Accelerators (LINAC)
Internal Beam Radiation
Applicators
Afterloader
Seeds
Capnographs
Gas Analyzers
Systemic Radiation
Global Radiotherapy Market, By Therapy Type:
External Beam Radiation Therapy
Stereotactic Radiosurgery (SRS)
Stereotactic Body Radiation Therapy (SBRT)
Intensity-modulated Radiation Therapy (IMRT)
Proton Therapy
Image-guided Radiotherapy (IGRT)
Volumetric Modulated Arc Therapy (VMAT)
Others
Internal Beam Radiation Therapy
Low-dose Rate Brachytherapy (LDR)
High-dose Rate Brachytherapy (HDR)
Image-guided Brachytherapy (IGBT)
Pulse Dose Rate Brachytherapy (PDR)
Systemic Radiation Therapy
Oral Radiotherapy
Intravenous Radiotherapy
Global Radiotherapy Market, By Application:
Prostate Cancer
Breast Cancer
Lung Cancer
Colorectal Cancer
Cervical Cancer
Others
Global Radiotherapy Market, By End User:
Hospitals
Oncology Clinics
Ambulatory Radiotherapy Centers
Others

Request a Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/1320

Radiotherapy, also known as radiation therapy, uses ionizing radiations that deliver targeted beams of radiation to kill and destroy cancer cells. The advanced technology used in radiotherapy works by bombarding cancerous cells with radiation to kill them, while minimizing damage to the healthy cells around them. Radiotherapy is the most potent and cost-effective treatment for cancer, and when integrated with advanced technologies such as image guided therapy, leads to enhanced control over tumor and toxicity.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

1001 4th Ave,, #3200, Seattle, WA 98154

This release was published on openPR.